Breast Cancer News

CancerConnect breast cancer news, tips, and features provide breaking research stories, helpful tips, and inspiring features related to ovarian cancer. The unique daily cancer news service evaluates all aspects of breast cancer research and reports on the developments that are most important to cancer patients and healthcare providers, while the tips and features offer insight into all aspects of breast cancer treatment and survivorship.

Share

Breast Cancer News


Vaccine Shows Promising Results for Early-Stage Breast Cancer Patients (February 15, 2017)

Immunotherapy is a fast growing area of cancer research. It involves developing therapies that use a patient’s own immune system to fight and kill cancer. Doctors at Moffitt Cancer Center in Tampa Florida... Continue Reading

Do Social Connections Lower Death Rates from Breast Cancer? (January 10, 2017)

Women diagnosed with breast cancer have greater rates of survival and lower rates of disease recurrences if they have more social ties, compared to women who are more socially isolated. These results were... Continue Reading

Keytruda®/Halaven® Combo May Be Effective in Advanced Triple-Negative Breast Cancer (January 9, 2017)

The investigative treatment combination including Keytruda® (pembrolizumab) plus Halaven® (eribulin) could provide a potential therapeutic option for patients with advanced triple-negative breast cancer... Continue Reading

ASTRO Expands Guidelines for Treatment of Breast Cancer with Accelerated Partial Breast Irradiation (January 5, 2017)

According to the American Society for Radiation Oncology (ASTRO) younger patients with early stage breast cancer and individuals with low-risk ductal carcinoma in situ (DCIS) can appropriately be treated... Continue Reading

Depression Drug Reduces Joint Pain for Women with Early Stage Breast Cancer (December 27, 2016)

A drug typically used to treat depression and anxiety can significantly reduce joint pain in postmenopausal women being treated for early stage breast cancer, according to new SWOG research to be presented... Continue Reading

Lynne Cohen Foundation: What an Incredible Year! (December 22, 2016)

WHAT AN INCREDIBLE YEAR! PREVENTIVE CARE CLINICS Our four Lynne Cohen Preventive Care Clinics feature multidisciplinary and personalized preventive care for over 9,500 women facing increased breast or... Continue Reading

UCLA Identifies Potential Cancer Treatment with Fewer Side Effects Than Chemotherapy (December 12, 2016)

By Stuart Wolpert, UCLA Asynthetic version of a rare toxin produced by a sea creature appears to hold promise for treating many different types of cancer while minimizing the harmful side effects of widely... Continue Reading

Aromatase Inhibitor–Associated Joint Pain Tends to Resolve Upon Treatment Completion (November 15, 2016)

A class of drugs known as aromatase inhibitors (AI) commonly used in the management of estrogen receptor-positive (ER+) breast cancer are associated with troublesome joint pain. In fact, as many as half... Continue Reading

Ribociclib Offers ‘Paradigm Shift’ in Advanced Breast Cancer (October 26, 2016)

The investigational drug ribociclib (formerly LEE011) when combined with Femera (letrozole) for the initial treatment of postmenopausal women with hormone-receptor positive (HR+) metastatic breast cancer... Continue Reading

Metastatic Breast Cancer- Ask the Expert, Your Questions Answered (October 11, 2016)

Ask the Expert session with Memorial Sloan Kettering Cancer Center’s Chau T. Dang, MD Dr. Dang discussed advances in the management of metastatic breast cancer and answered your questions in a live... Continue Reading

More Breast Cancer News

Latest Breast Cancer News By Stage


Screening and Prevention

Lynne Cohen Foundation: What an Incredible Year! (December 22, 2016)

WHAT AN INCREDIBLE YEAR! PREVENTIVE CARE CLINICS Our four Lynne Cohen Preventive Care Clinics feature multidisciplinary and personalized preventive care for over 9,500 women facing increased breast or ovarian cancer risk. At each of our Preventive Care... Continue Reading

Breast Cancer Awareness Month: Ask Questions, Get Connected (October 1, 2016)

What does breast cancer awareness month mean to you? We’d like to hear from you—join us on facebook, twitter, or CancerConnect and join the discussion. On October 10th  at 6pm EDT, we will have a live web chat with Memorial Sloan Kettering Cancer... Continue Reading

Counsyl Announces Major Oncology Expansion to Advance Genetic Screening for Cancer Risk (May 25, 2016)

Counsyl launches oncology business unit, an expanded test to assess risk for inherited forms of cancer, and tools to improve genetic screening rates across the healthcare system Counsyl, a DNA testing and genetic counseling service, today announced... Continue Reading

Lynne Cohen Foundation Launches CancerConnect Social Media Platform for Women Facing Increased Risk for Ovarian and Breast Cancers (April 15, 2016)

Santa Monica, CA/Sun Valley ID– With the launch of the CancerConnect online community, the Lynne Cohen Foundation now offers a specialized social network for women facing increased risk for ovarian and breast cancers. This community furthers the foundation’s... Continue Reading

3D Mammography Proves More Accurate in Breast Cancer Detection (March 31, 2016)

Longer follow-up evaluating digital breast tomosynthesis (DBT), also referred to as 3D mammography, demonstrates its continued effectiveness compared to standard digital mammography (DM) when screening for breast cancer. These results were recently published... Continue Reading

More Screening and Prevention

Carcinoma in Situ

ASTRO Expands Guidelines for Treatment of Breast Cancer with Accelerated Partial Breast Irradiation (January 5, 2017)

According to the American Society for Radiation Oncology (ASTRO) younger patients with early stage breast cancer and individuals with low-risk ductal carcinoma in situ (DCIS) can appropriately be treated with accelerated partial breast irradiation (APBI). Many... Continue Reading

Breast Cancer Awareness Month: Ask Questions, Get Connected (October 1, 2016)

What does breast cancer awareness month mean to you? We’d like to hear from you—join us on facebook, twitter, or CancerConnect and join the discussion. On October 10th  at 6pm EDT, we will have a live web chat with Memorial Sloan Kettering Cancer... Continue Reading

Shorter Radiation Course Confirmed as Option for Early-Stage Breast Cancer (June 29, 2016)

Results of a recently published clinical study suggest that early-stage breast cancer patients treated with a shorter course of whole breast radiation with higher radiation doses per fraction experience equivalent cosmetic, functional, and pain outcomes... Continue Reading

Men’s Views of the Women They Love Post-Mastectomy (April 11, 2016)

By John Leifer Despite five decades of effort by feminists, our society continues to bombard women with the message that their femininity and sexual attractiveness are directly tied to their bust-line. So it comes as no surprise that the loss of a woman’s... Continue Reading

ASCO Publishes Breast Cancer Survivorship Guidelines (January 25, 2016)

The American Society of Clinical Oncology (ASCO), in collaboration with the American Cancer Society (ACS), have released updated guidelines regarding follow-up care for breast cancer survivors. The updated guidelines were recently published in the Journal... Continue Reading

More Carcinoma in Situ

Stage I - Node Negative

ASTRO Expands Guidelines for Treatment of Breast Cancer with Accelerated Partial Breast Irradiation (January 5, 2017)

According to the American Society for Radiation Oncology (ASTRO) younger patients with early stage breast cancer and individuals with low-risk ductal carcinoma in situ (DCIS) can appropriately be treated with accelerated partial breast irradiation (APBI). Many... Continue Reading

Depression Drug Reduces Joint Pain for Women with Early Stage Breast Cancer (December 27, 2016)

A drug typically used to treat depression and anxiety can significantly reduce joint pain in postmenopausal women being treated for early stage breast cancer, according to new SWOG research to be presented Friday at a special plenary presentation at the... Continue Reading

Breast Cancer Awareness Month: Ask Questions, Get Connected (October 1, 2016)

What does breast cancer awareness month mean to you? We’d like to hear from you—join us on facebook, twitter, or CancerConnect and join the discussion. On October 10th  at 6pm EDT, we will have a live web chat with Memorial Sloan Kettering Cancer... Continue Reading

MammaPrint Might Help Identify Breast Cancer Patients Who Could Safely Opt Out of Chemo (September 7, 2016)

MammaPrint, a 70-gene signature test, might help healthcare providers and patients determine whether they will derive a benefit from chemotherapy, or if they could safely choose to not receive chemotherapy for early-stage breast cancer. These results... Continue Reading

Neratinib Improves Cancer-Free Survival in Early Breast Cancer (July 27, 2016)

The targeted agent neratinib (PB272), which is still in clinical trials, demonstrated an improvement in cancer-free survival when used after Herceptin® (trastuzumab) in early-stage, HER2-positive breast cancer. Approximately 20-30% of breast cancer is... Continue Reading

More Stage I Node Negative

Stages II-III

Breast Cancer Awareness Month: Ask Questions, Get Connected (October 1, 2016)

What does breast cancer awareness month mean to you? We’d like to hear from you—join us on facebook, twitter, or CancerConnect and join the discussion. On October 10th  at 6pm EDT, we will have a live web chat with Memorial Sloan Kettering Cancer... Continue Reading

Neratinib Improves Cancer-Free Survival in Early Breast Cancer (July 27, 2016)

The targeted agent neratinib (PB272), which is still in clinical trials, demonstrated an improvement in cancer-free survival when used after Herceptin® (trastuzumab) in early-stage, HER2-positive breast cancer. Approximately 20-30% of breast cancer is... Continue Reading

Some Premenopausal Women Benefit from Exemestane Compared to Tamoxifen (April 28, 2016)

Among premenopausal women with hormone-positive, early breast cancer who are considered to have a high risk of a cancer recurrence, the use of Aromasin® (exemestane) versus tamoxifen improves cancer-free survival at 5 years. These results were recently... Continue Reading

Men’s Views of the Women They Love Post-Mastectomy (April 11, 2016)

By John Leifer Despite five decades of effort by feminists, our society continues to bombard women with the message that their femininity and sexual attractiveness are directly tied to their bust-line. So it comes as no surprise that the loss of a woman’s... Continue Reading

Dose-Dense Chemotherapy for Premenopausal Breast Cancer Improves Survival (March 28, 2016)

Premenopausal women who have been diagnosed with breast cancer have improved survival if their chemotherapy doses are delivered every two weeks, compared to every three weeks. These results were recently presented at the 2016 European Breast Cancer Conference... Continue Reading

More Stages II and III

Inflammatory

Breast Cancer Awareness Month: Ask Questions, Get Connected (October 1, 2016)

What does breast cancer awareness month mean to you? We’d like to hear from you—join us on facebook, twitter, or CancerConnect and join the discussion. On October 10th  at 6pm EDT, we will have a live web chat with Memorial Sloan Kettering Cancer... Continue Reading

Men’s Views of the Women They Love Post-Mastectomy (April 11, 2016)

By John Leifer Despite five decades of effort by feminists, our society continues to bombard women with the message that their femininity and sexual attractiveness are directly tied to their bust-line. So it comes as no surprise that the loss of a woman’s... Continue Reading

ASCO Publishes Breast Cancer Survivorship Guidelines (January 25, 2016)

The American Society of Clinical Oncology (ASCO), in collaboration with the American Cancer Society (ACS), have released updated guidelines regarding follow-up care for breast cancer survivors. The updated guidelines were recently published in the Journal... Continue Reading

Breast Cancer Research: Have We Made Progress? (January 27, 2015)

Published results from research studies in breast cancer in the last year represent several practice changing milestones. CancerConnect News coverage of advances in the management of breast cancer included the following key developments: 2014: Have we... Continue Reading

October Is National Breast Cancer Awareness Month (October 10, 2014)

What does breast cancer awareness month mean to you? We’d like to hear from you—join us on facebook, twitter, or CancerConnect and join the discussion. On October 23rd at 6pm EDT, we will have a live web chat with UC San Diego Moores Cancer Center... Continue Reading

More Inflammatory

Metastatic

Ribociclib Offers ‘Paradigm Shift’ in Advanced Breast Cancer (October 26, 2016)

The investigational drug ribociclib (formerly LEE011) when combined with Femera (letrozole) for the initial treatment of postmenopausal women with hormone-receptor positive (HR+) metastatic breast cancer leads to improved survival without cancer recurrence. The... Continue Reading

Metastatic Breast Cancer- Ask the Expert, Your Questions Answered (October 11, 2016)

Ask the Expert session with Memorial Sloan Kettering Cancer Center’s Chau T. Dang, MD Dr. Dang discussed advances in the management of metastatic breast cancer and answered your questions in a live web chat on October 10, 2016 on CancerConnect. Dr.... Continue Reading

Breast Cancer Awareness Month: Ask Questions, Get Connected (October 1, 2016)

What does breast cancer awareness month mean to you? We’d like to hear from you—join us on facebook, twitter, or CancerConnect and join the discussion. On October 10th  at 6pm EDT, we will have a live web chat with Memorial Sloan Kettering Cancer... Continue Reading

ASCO Treatment Recommendations for HR+, Metastatic Breast Cancer (September 5, 2016)

The American Society of Clinical Oncology (ASCO) recently convened an Expert Panel to create recommendations for endocrine therapy for women with hormone-receptor (HR)-positive, metastatic breast cancer. The panel conducted “a systematic review of evidence... Continue Reading

Ribociclib Receives FDA Breakthrough Therapy Designation as First-line Treatment for HR+/HER2- Advanced Breast Cancer (August 3, 2016)

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ribociclib (LEE011) in combination with Femara® (letrozole) for the treatment of hormone receptor positive, human epidermal growth factor receptor 2-negative (HR+/HER2-)... Continue Reading

More Metastatic

Recurrent

Metastatic Breast Cancer- Ask the Expert, Your Questions Answered (October 11, 2016)

Ask the Expert session with Memorial Sloan Kettering Cancer Center’s Chau T. Dang, MD Dr. Dang discussed advances in the management of metastatic breast cancer and answered your questions in a live web chat on October 10, 2016 on CancerConnect. Dr.... Continue Reading

Breast Cancer Awareness Month: Ask Questions, Get Connected (October 1, 2016)

What does breast cancer awareness month mean to you? We’d like to hear from you—join us on facebook, twitter, or CancerConnect and join the discussion. On October 10th  at 6pm EDT, we will have a live web chat with Memorial Sloan Kettering Cancer... Continue Reading

Ribociclib Receives FDA Breakthrough Therapy Designation as First-line Treatment for HR+/HER2- Advanced Breast Cancer (August 3, 2016)

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ribociclib (LEE011) in combination with Femara® (letrozole) for the treatment of hormone receptor positive, human epidermal growth factor receptor 2-negative (HR+/HER2-)... Continue Reading

Directly Involving Patients Drives Participation in Metastatic Breast Cancer Study (June 22, 2016)

A clinical study to accelerate research in metastatic breast cancer has rapidly enrolled participants through direct collaboration with patients. These results were recently presented at the 2016 annual meeting of the American Society of Clinical Oncology... Continue Reading

ASCO Publishes Breast Cancer Survivorship Guidelines (January 25, 2016)

The American Society of Clinical Oncology (ASCO), in collaboration with the American Cancer Society (ACS), have released updated guidelines regarding follow-up care for breast cancer survivors. The updated guidelines were recently published in the Journal... Continue Reading

More Recurrent

Supportive Care

Breast Cancer Awareness Month: Ask Questions, Get Connected (October 1, 2016)

What does breast cancer awareness month mean to you? We’d like to hear from you—join us on facebook, twitter, or CancerConnect and join the discussion. On October 10th  at 6pm EDT, we will have a live web chat with Memorial Sloan Kettering Cancer... Continue Reading

ASCO Publishes Breast Cancer Survivorship Guidelines (January 25, 2016)

The American Society of Clinical Oncology (ASCO), in collaboration with the American Cancer Society (ACS), have released updated guidelines regarding follow-up care for breast cancer survivors. The updated guidelines were recently published in the Journal... Continue Reading

Breast Cancer Research: Have We Made Progress? (January 27, 2015)

Published results from research studies in breast cancer in the last year represent several practice changing milestones. CancerConnect News coverage of advances in the management of breast cancer included the following key developments: 2014: Have we... Continue Reading

October Is National Breast Cancer Awareness Month (October 10, 2014)

What does breast cancer awareness month mean to you? We’d like to hear from you—join us on facebook, twitter, or CancerConnect and join the discussion. On October 23rd at 6pm EDT, we will have a live web chat with UC San Diego Moores Cancer Center... Continue Reading

Risk of Breast Cancer Recurrence Doesn’t Increase with TNF Inhibitor Use (August 28, 2014)

According to the results of a recently published study from Swedish investigators treatment with tumor necrosis factor inhibitors (TNF) does not appear to increase the rate of breast cancer recurrence among patients with rheumatoid arthritis (RA).  The... Continue Reading

More Supportive Care

CancerConnect Cancer Commuity & Discussions


Cancer Types

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS